• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于混合不确定性的集成区块链赋能的多渠道疫苗供应链网络。

An integrated blockchain-enabled multi-channel vaccine supply chain network under hybrid uncertainties.

机构信息

Department of Industrial Engineering, Faculty of Engineering, Alzahra University, Tehran, Iran.

Department of Industrial Engineering, University of Torbat Heydarieh, Torbat Heydarieh, Iran.

出版信息

Sci Rep. 2024 Oct 1;14(1):22829. doi: 10.1038/s41598-024-67071-0.

DOI:10.1038/s41598-024-67071-0
PMID:39353990
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11445526/
Abstract

The recent pandemic caused by COVID-19 is considered an unparalleled disaster in history. Developing a vaccine distribution network can provide valuable support to supply chain managers. Prioritizing the assigned available vaccines is crucial due to the limited supply at the final stage of the vaccine supply chain. In addition, parameter uncertainty is a common occurrence in a real supply chain, and it is essential to address this uncertainty in planning models. On the other hand, blockchain technology, being at the forefront of technological advancements, has the potential to enhance transparency within supply chains. Hence, in this study, we develop a new mathematical model for designing a COVID-19 vaccine supply chain network. In this regard, a multi-channel network model is designed to minimize total cost and maximize transparency with blockchain technology consideration. This addresses the uncertainty in supply, and a scenario-based multi-stage stochastic programming method is presented to handle the inherent uncertainty in multi-period planning horizons. In addition, fuzzy programming is used to face the uncertain price and quality of vaccines. Vaccine assignment is based on two main policies including age and population-based priority. The proposed model and method are validated and tested using a real-world case study of Iran. The optimum design of the COVID-19 vaccine supply chain is determined, and some comprehensive sensitivity analyses are conducted on the proposed model. Generally, results demonstrate that the multi-stage stochastic programming model meaningfully reduces the objective function value compared to the competitor model. Also, the results show that one of the efficient factors in increasing satisfied demand and decreasing shortage is the price of each type of vaccine and its agreement.

摘要

由 COVID-19 引发的最近的大流行被认为是历史上一场空前的灾难。开发疫苗分发网络可以为供应链经理提供有价值的支持。由于疫苗供应链的最后阶段供应有限,优先考虑分配的可用疫苗至关重要。此外,参数不确定性在实际供应链中很常见,在规划模型中解决这种不确定性至关重要。另一方面,区块链技术处于技术进步的前沿,有可能提高供应链的透明度。因此,在这项研究中,我们开发了一个新的用于设计 COVID-19 疫苗供应链网络的数学模型。在这方面,设计了一个多渠道网络模型,以最小化总成本并最大限度地提高区块链技术的透明度。这解决了供应的不确定性,并提出了一种基于情景的多阶段随机规划方法来处理多期规划中固有的不确定性。此外,模糊规划用于应对疫苗价格和质量的不确定性。疫苗分配基于包括年龄和基于人口的优先级在内的两项主要政策。使用伊朗的实际案例研究对所提出的模型和方法进行了验证和测试。确定了 COVID-19 疫苗供应链的最优设计,并对所提出的模型进行了一些全面的敏感性分析。一般来说,结果表明,多阶段随机规划模型与竞争模型相比,显著降低了目标函数值。此外,结果表明,增加满足需求和减少短缺的有效因素之一是每种疫苗的价格及其协议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/9758a8a17d0e/41598_2024_67071_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/9e320e4d4784/41598_2024_67071_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/872ee7bb3d83/41598_2024_67071_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/4703ff41dfc7/41598_2024_67071_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/a550a829902f/41598_2024_67071_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/acc5c3ba9ca2/41598_2024_67071_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/0b38502441cb/41598_2024_67071_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/5922eda71cd4/41598_2024_67071_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/919434f4d947/41598_2024_67071_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/fc4d921be12c/41598_2024_67071_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/9a9563c724d6/41598_2024_67071_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/aa075e5f976b/41598_2024_67071_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/fcd311e2e87e/41598_2024_67071_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/c88d8be67898/41598_2024_67071_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/fe5f694422a9/41598_2024_67071_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/cfb85bea7cd1/41598_2024_67071_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/b4b3dab71f42/41598_2024_67071_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/9758a8a17d0e/41598_2024_67071_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/9e320e4d4784/41598_2024_67071_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/872ee7bb3d83/41598_2024_67071_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/4703ff41dfc7/41598_2024_67071_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/a550a829902f/41598_2024_67071_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/acc5c3ba9ca2/41598_2024_67071_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/0b38502441cb/41598_2024_67071_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/5922eda71cd4/41598_2024_67071_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/919434f4d947/41598_2024_67071_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/fc4d921be12c/41598_2024_67071_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/9a9563c724d6/41598_2024_67071_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/aa075e5f976b/41598_2024_67071_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/fcd311e2e87e/41598_2024_67071_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/c88d8be67898/41598_2024_67071_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/fe5f694422a9/41598_2024_67071_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/cfb85bea7cd1/41598_2024_67071_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/b4b3dab71f42/41598_2024_67071_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cd5/11445526/9758a8a17d0e/41598_2024_67071_Fig17_HTML.jpg

相似文献

1
An integrated blockchain-enabled multi-channel vaccine supply chain network under hybrid uncertainties.基于混合不确定性的集成区块链赋能的多渠道疫苗供应链网络。
Sci Rep. 2024 Oct 1;14(1):22829. doi: 10.1038/s41598-024-67071-0.
2
Designing an integrated blockchain-enabled supply chain network under uncertainty.设计一个在不确定性下的集成区块链供应链网络。
Sci Rep. 2023 Mar 9;13(1):3928. doi: 10.1038/s41598-023-30439-9.
3
An equitable and accessible vaccine supply chain network in the epidemic outbreak of COVID-19 under uncertainty.在不确定性下新冠疫情爆发期间公平且可及的疫苗供应链网络
J Ambient Intell Humaniz Comput. 2022 Jun 7:1-25. doi: 10.1007/s12652-022-03865-2.
4
Blockchain Powered Vaccine Efficacy for Pharma Sector.区块链赋能制药行业疫苗效力。
Comput Math Methods Med. 2022 Sep 10;2022:4862742. doi: 10.1155/2022/4862742. eCollection 2022.
5
Designing an optimization model for the vaccine supply chain during the COVID-19 pandemic.设计新冠疫情期间疫苗供应链的优化模型。
Expert Syst Appl. 2023 Mar 15;214:119009. doi: 10.1016/j.eswa.2022.119009. Epub 2022 Oct 26.
6
Improving the distribution of covid-19 vaccines using the blockchain technology: the Italian case study.利用区块链技术改善新冠疫苗的分配:意大利案例研究。
Procedia Comput Sci. 2023;217:366-375. doi: 10.1016/j.procs.2022.12.232. Epub 2023 Jan 13.
7
Optimizing two-dose vaccine resource allocation to combat a pandemic in the context of limited supply: The case of COVID-19.优化两剂疫苗资源分配以应对有限供应情况下的大流行:以 COVID-19 为例。
Front Public Health. 2023 Apr 24;11:1129183. doi: 10.3389/fpubh.2023.1129183. eCollection 2023.
8
Supply chain traceability and counterfeit detection of COVID-19 vaccines using novel blockchain-based system.使用基于区块链的新型系统对新冠疫苗进行供应链可追溯性和假冒检测。
Expert Syst Appl. 2023 Oct 15;228:120293. doi: 10.1016/j.eswa.2023.120293. Epub 2023 May 9.
9
Design of a Vaccine Passport Validation System Using Blockchain-based Architecture: Development Study.基于区块链架构的疫苗护照验证系统设计:开发研究。
JMIR Public Health Surveill. 2022 Apr 26;8(4):e32411. doi: 10.2196/32411.
10
Designing a sustainable-resilient-responsive supply chain network considering uncertainty in the COVID-19 era.在新冠疫情时代考虑不确定性因素设计可持续、有韧性且能快速响应的供应链网络。
Expert Syst Appl. 2023 Oct 1;227:120334. doi: 10.1016/j.eswa.2023.120334. Epub 2023 May 6.

本文引用的文献

1
Supply chain planning of vaccine and pharmaceutical clusters under uncertainty: The case of COVID-19.不确定性下疫苗与药品集群的供应链规划:以新冠疫情为例
Socioecon Plann Sci. 2023 Jun;87:101602. doi: 10.1016/j.seps.2023.101602. Epub 2023 Apr 18.
2
Optimizing the COVID-19 cold chain vaccine distribution network with medical waste management: A robust optimization approach.通过医疗废物管理优化新冠冷链疫苗配送网络:一种稳健优化方法
Expert Syst Appl. 2023 Nov 1;229:120510. doi: 10.1016/j.eswa.2023.120510. Epub 2023 May 19.
3
Designing a sustainable-resilient-responsive supply chain network considering uncertainty in the COVID-19 era.
在新冠疫情时代考虑不确定性因素设计可持续、有韧性且能快速响应的供应链网络。
Expert Syst Appl. 2023 Oct 1;227:120334. doi: 10.1016/j.eswa.2023.120334. Epub 2023 May 6.
4
A robust optimization problem for drone-based equitable pandemic vaccine distribution with uncertain supply.一个基于无人机的公平大流行疫苗分配的鲁棒优化问题,供应存在不确定性。
Omega. 2023 Sep;119:102872. doi: 10.1016/j.omega.2023.102872. Epub 2023 Mar 21.
5
Designing an integrated blockchain-enabled supply chain network under uncertainty.设计一个在不确定性下的集成区块链供应链网络。
Sci Rep. 2023 Mar 9;13(1):3928. doi: 10.1038/s41598-023-30439-9.
6
Designing a sustainable reverse supply chain network for COVID-19 vaccine waste under uncertainty.在不确定性条件下为新冠疫苗废弃物设计可持续的逆向供应链网络
Comput Ind Eng. 2022 Dec;174:108808. doi: 10.1016/j.cie.2022.108808. Epub 2022 Nov 11.
7
Social equity-based distribution networks design for the COVID-19 vaccine.基于社会公平的新冠疫苗配送网络设计
Int J Prod Econ. 2022 Aug;250:108684. doi: 10.1016/j.ijpe.2022.108684. Epub 2022 Oct 22.
8
Designing an optimization model for the vaccine supply chain during the COVID-19 pandemic.设计新冠疫情期间疫苗供应链的优化模型。
Expert Syst Appl. 2023 Mar 15;214:119009. doi: 10.1016/j.eswa.2022.119009. Epub 2022 Oct 26.
9
A new vaccine supply chain network under COVID-19 conditions considering system dynamic: Artificial intelligence algorithms.一种考虑系统动力学的 COVID-19 条件下的新型疫苗供应链网络:人工智能算法
Socioecon Plann Sci. 2023 Feb;85:101378. doi: 10.1016/j.seps.2022.101378. Epub 2022 Aug 8.
10
Bi-objective optimization of a stochastic resilient vaccine distribution network in the context of the COVID-19 pandemic.新冠疫情背景下随机弹性疫苗配送网络的双目标优化
Omega. 2022 Dec;113:102725. doi: 10.1016/j.omega.2022.102725. Epub 2022 Jul 28.